10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q2 2013

Filing Information

Form Type	10-Q
Accession Number	`0001144204-13-043344`
Period End Date	20130630
Filing Date	20130806
Fiscal Year	2013
Fiscal Period	Q2
XBRL Instance	enzn-20130630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 105 Cash Flow Statement 58

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.46M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$59.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$104.32M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$77.35M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$3.00M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$119.39M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.90M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.29M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$15.75M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total current assets	`AssetsCurrent`	$198.64M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$902.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	43.67M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	43.73M	shares	Point-in-time
Total assets	`Assets`	$199.78M	USD	Point-in-time
Total assets	`Assets`	$16.65M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.67M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.73M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$776.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$596.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$2.00M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$5.69M	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$115.85M	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$122.31M	USD	Point-in-time
Total liabilities	`Liabilities`	$122.31M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.60M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2013 and December 31, 2012	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2013 and December 31, 2012	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 43,731,646 shares at June 30, 2013 and 43,674,170 shares at December 31, 2012	`CommonStockValue`	$437.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 43,731,646 shares at June 30, 2013 and 43,674,170 shares at December 31, 2012	`CommonStockValue`	$437.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$154.35M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$224.80M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$83.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-147.85M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-140.74M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$77.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$14.05M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$199.78M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$16.65M	USD	Point-in-time

Income Statement 105 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$17.61M	USD	2 Qtrs
Royalties	`RoyaltyRevenue`	$9.77M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$20.09M	USD	2 Qtrs
Royalties	`RoyaltyRevenue`	$8.04M	USD	1 Quarter
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$136.00K	USD	2 Qtrs
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	-	USD	2 Qtrs
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	-	USD	1 Quarter
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$33.00K	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$12.00K	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$604.00K	USD	2 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$427.00K	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$631.00K	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$10.23M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$18.24M	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$8.06M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$20.83M	USD	2 Qtrs
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$12.59M	USD	2 Qtrs
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$294.00K	USD	1 Quarter
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$1.87M	USD	2 Qtrs
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$5.67M	USD	1 Quarter
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$113.00K	USD	2 Qtrs
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	-	USD	2 Qtrs
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$28.00K	USD	1 Quarter
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	-	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$8.03M	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$5.35M	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$4.36M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$2.40M	USD	1 Quarter
Restructuring charges	`RestructuringCharges`	$464.00K	USD	1 Quarter
Restructuring charges	`RestructuringCharges`	$-107.00K	USD	2 Qtrs
Restructuring charges	`RestructuringCharges`	$2.50M	USD	1 Quarter
Restructuring charges	`RestructuringCharges`	$-70.00K	USD	1 Quarter
Restructuring charges	`RestructuringCharges`	$2.97M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$10.19M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$20.63M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$3.16M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$9.99M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$4.90M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$8.05M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$242.00K	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$206.00K	USD	2 Qtrs
Investment income, net	`InvestmentIncomeNet`	$103.00K	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$530.00K	USD	2 Qtrs
Investment income, net	`InvestmentIncomeNet`	$1.00M	USD	2 Qtrs
Investment income, net	`InvestmentIncomeNet`	$523.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$850.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.36M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.78M	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.12M	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$646.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$-193.00K	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$866.00K	USD	2 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$-97.00K	USD	1 Quarter
Total other expense	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-728.00K	USD	2 Qtrs
Total other expense	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-1.97M	USD	2 Qtrs
Total other expense	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-101.00K	USD	1 Quarter
Total other expense	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-938.00K	USD	1 Quarter
Income (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-696.00K	USD	1 Quarter
Income (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.77M	USD	2 Qtrs
Income (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.32M	USD	2 Qtrs
Income (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.80M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$33.00K	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$80.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$33.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$213.00K	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$7.11M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$4.72M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-729.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-1.80M	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.11	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.04	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.02	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.16	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.04	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.09	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.14	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.02	USD	1 Quarter
Weighted-average shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	43.71M	shares	2 Qtrs
Weighted-average shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	43.73M	shares	1 Quarter
Weighted-average shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.23M	shares	2 Qtrs
Weighted-average shares - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.18M	shares	1 Quarter
Weighted-average shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.18M	shares	1 Quarter
Weighted-average shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.23M	shares	2 Qtrs
Weighted-average shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	55.27M	shares	1 Quarter
Weighted-average shares - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	58.20M	shares	2 Qtrs
Special cash dividend paid per common share	`CommonStockDividendsPerShareCashPaid`	$1.60	USD	1 Quarter
Special cash dividend paid per common share	`CommonStockDividendsPerShareCashPaid`	-	USD	2 Qtrs
Special cash dividend paid per common share	`CommonStockDividendsPerShareCashPaid`	$1.60	USD	2 Qtrs
Special cash dividend paid per common share	`CommonStockDividendsPerShareCashPaid`	-	USD	1 Quarter
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$234.00K	USD	2 Qtrs
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00K	USD	1 Quarter
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-57.00K	USD	1 Quarter
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$480.00K	USD	2 Qtrs
Reclassification adjustment for realized losses (gains) on sales included in net income (loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$16.00K	USD	1 Quarter
Reclassification adjustment for realized losses (gains) on sales included in net income (loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$320.00K	USD	2 Qtrs
Reclassification adjustment for realized losses (gains) on sales included in net income (loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$39.00K	USD	1 Quarter
Reclassification adjustment for realized losses (gains) on sales included in net income (loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$-19.00K	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-42.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-73.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-86.00K	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$499.00K	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$4.68M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-802.00K	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$7.02M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-1.30M	USD	2 Qtrs

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$7.11M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$4.72M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-729.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-1.80M	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$2.57M	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$159.00K	USD	2 Qtrs
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	$309.00K	USD	2 Qtrs
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	$193.00K	USD	2 Qtrs
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	$-366.00K	USD	2 Qtrs
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	$982.00K	USD	2 Qtrs
(Gain) loss on sales of marketable securities	`MarketableSecuritiesGainLoss`	$320.00K	USD	2 Qtrs
(Gain) loss on sales of marketable securities	`MarketableSecuritiesGainLoss`	$-19.00K	USD	2 Qtrs
Losses on early retirement of notes payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Losses on early retirement of notes payable	`GainsLossesOnExtinguishmentOfDebt`	$-212.00K	USD	2 Qtrs
Amortization of purchase premium on marketable securities	`AmortizationOfPurchasePremiumOnMarketableSecurities`	$731.00K	USD	2 Qtrs
Amortization of purchase premium on marketable securities	`AmortizationOfPurchasePremiumOnMarketableSecurities`	$1.56M	USD	2 Qtrs
(Gain) on sale of assets	`GainLossOnDispositionOfAssets`	-	USD	2 Qtrs
(Gain) on sale of assets	`GainLossOnDispositionOfAssets`	$865.00K	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$7.25M	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$3.41M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.40M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.23M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.00K	USD	2 Qtrs
Proceeds from sale of assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Proceeds from sale of assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$942.00K	USD	2 Qtrs
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$83.28M	USD	2 Qtrs
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$115.89M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$105.54M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$116.84M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-22.27M	USD	2 Qtrs
Common stock dividend	`PaymentsOfDividendsCommonStock`	$69.97M	USD	2 Qtrs
Common stock dividend	`PaymentsOfDividendsCommonStock`	-	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$5.32M	USD	2 Qtrs
Retirement of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	$-115.85M	USD	2 Qtrs
Retirement of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	-	USD	2 Qtrs
Repurchases of notes payable	`RepurchaseOfNotesPayable`	$-13.86M	USD	2 Qtrs
Repurchases of notes payable	`RepurchaseOfNotesPayable`	-	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$62.00K	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$12.00K	USD	2 Qtrs
Withholding taxes - stock based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$123.00K	USD	2 Qtrs
Withholding taxes - stock based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$76.00K	USD	2 Qtrs
Withdrawals/proceeds from employee stock purchase plan	`ProceedsFromStockPlans`	$-33.00K	USD	2 Qtrs
Withdrawals/proceeds from employee stock purchase plan	`ProceedsFromStockPlans`	$-21.00K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-19.21M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-185.96M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-44.88M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-65.89M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.46M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$59.44M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$104.32M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$77.35M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.46M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$59.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$104.32M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$77.35M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.